As a natural prebiotic in human milk, 2′-fucosyllactose (2′-FL) is actively used in infant
formula (IF). However, the 2′-FL influence on the improvement of gut microbiota and the …

Fucosyllactose (2′-FL), the main component of human milk oligosaccharides (HMOs), has
been shown to prevent intestinal diseases and its underlying mechanism remains unclear …

Background Breast milk is critical for neonates, providing the necessary energy, nutrients,
and bioactive compounds for growth and development. Research indicated that human milk …

As the richest component in human milk oligosaccharides (HMOs), 2'-fucosyllactose (2'-FL)
can reduce the colonization of harmful microbiota in vivo, thus lowering the risk of infection; …

Food allergy (FA) has become a prominent problem in public health. 2′-Fucosyllactose
(2′-FL) was reported to alleviate FA symptoms; however, the regulatory mechanism is still …

fucosyllactose (2′-FL) is one of the most prevalent milk oligosaccharides. In this study, the
anti-obesity effect of 2′-FL was explored in high-fat diet (HFD)-fed mice. Results showed …

In breast milk, 2′-Fucosyllactose (2′ FL) is the most abundant breast milk oligosaccharide
and can selectively promote the proliferation of bifidobacteria. This study aimed to explore …

Obesity is characterized by fat accumulation, chronic inflammation and impaired satiety
signaling, which may be due in part to gut microbial dysbiosis. Manipulations of the gut …

Observational evidence suggests that human milk oligosaccharides (HMOs) promote the
growth of commensal bacteria in early life and adulthood. However, the mechanisms by …

Gut microbiota dysbiosis, together with goblet cells dysfunction has been observed in
ulcerative colitis cases. This study aims to evaluate the potential of 2′-fucosyllactose (2 …